In Vitro Effects of Combining Genistein with Aromatase Inhibitors: Concerns Regarding Its Consumption during Breast Cancer Treatment
Molecules · 2023
DOI: 10.3390/molecules28134893 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Patrícia H A Bezerra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Cytology, Department of Clinical Analyses, Toxicology and Food Science, School of Pharmaceutical Sciences of Ribeirão Preto, U…. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, São Paulo Research Foundation, Coordenação de Aperfeicoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Introduction
The third-generation of aromatase inhibitors (AIs)—Exemestane (Exe), Letrozole (Let), and Anastrozole (Ana)—is the main therapeutic approach applied for estrogen receptor-positive (ER+) breast cancer (BC), the most common neoplasm in women worldwide. Despite their success, the development of resistance limits their efficacy. Genistein (G), a phytoestrogen present in soybean, has promising anticancer properties in ER+ BC cells, even when combined with anticancer drugs. Thus, the potential beneficial effects of combining G with AIs were investigated in sensitive (MCF7-aro) and resistant (LTEDaro) BC cells.
Methods
The effects on cell proliferation and expression of aromatase, ERα/ERβ, and AR receptors were evaluated.
Results
Unlike the combination of G with Ana or Let, which negatively affects the Ais’ therapeutic efficacy, G enhanced the anticancer properties of the steroidal AI Exe, increasing the antiproliferative effect and apoptosis relative to Exe. The hormone targets studied were not affected by this combination when compared with Exe.
Conclusions
This is the first in vitro study that highlights the potential benefit of G as an adjuvant therapy with Exe, emphasizing, however, that soy derivatives widely used in the diet or applied as auxiliary medicines may increase the risk of adverse interactions with nonsteroidal AIs used in therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Clinical Cytology, Department of Clinical Analyses, Toxicology and Food Science, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040-903, SP, Brazil.
- UCIBIO.REQUIMTE, Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, nº 228, 4050-313 Porto, Portugal.
- Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, nº 228, 4050-313 Porto, Portugal.
ORCID-Profile: Georgina Correia-da-Silva
Förderung
- Fundação para a Ciência e Tecnologia
- São Paulo Research Foundation
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Coordination for the Improvement of Higher Education Personnel
Zitieren
APA
Bezerra, P. H. A., Amaral, C., Almeida, C. F., Correia-da-Silva, G., Torqueti, M. R., & Teixeira, N. (2023). In Vitro Effects of Combining Genistein with Aromatase Inhibitors: Concerns Regarding Its Consumption during Breast Cancer Treatment. Molecules. https://doi.org/10.3390/molecules28134893
Vancouver
Bezerra PHA, Amaral C, Almeida CF, Correia-da-Silva G, Torqueti MR, Teixeira N. In Vitro Effects of Combining Genistein with Aromatase Inhibitors: Concerns Regarding Its Consumption during Breast Cancer Treatment. Molecules. 2023. doi:10.3390/molecules28134893
BibTeX
@article{Bezerra2023,
author = {Bezerra, Patrícia H A and Amaral, Cristina and Almeida, Cristina F and Correia-da-Silva, Georgina and Torqueti, Maria Regina and Teixeira, Natércia},
title = {In Vitro Effects of Combining Genistein with Aromatase Inhibitors: Concerns Regarding Its Consumption during Breast Cancer Treatment},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28134893}
}
EUVIMED